Research Insight
Research Insight
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial
Resverlogix Corp announced that it has received approval from Health Canada, Therapeutic Products Directorate, to proceed with a clinical trial with its lead compound apabetalone in patients with Fabry disease.
Donald McCaffrey, President and CEO, stated, "We are extremely pleased...
Research Insight
Partners HealthCare, GE Healthcare announce AI partnership into every aspect of the patient journey
Partners HealthCare and GE Healthcare announced a 10-year collaboration to rapidly develop, validate and strategically integrate deep learning technology across the entire continuum of care.
The collaboration will be executed through the newly formed Massachusetts General Hospital and Brigham and Women’s...
Research Insight
ContraVir Pharma to advance second-gen formulation of Tenofovir Exalidex
ContraVir Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced it is developing a second-generation formulation of TXLâ„¢, the Company’s proprietary liver-targeting prodrug of the antiviral agent tenofovir for treating chronic HBV.  Â
Subsequent...
Research Insight
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
BD (Becton, Dickinson and Company) , a leading global medical technology company announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in clinical laboratories ─ a critical...
Research Insight
Novotech signs MOU with South Korea leading medical center,the Asan Medical Center
Asia Pacific specialist CRO Novotech announced it has signed a Memorandum of Understanding (MOU) with South Korea’s largest medical institution – The Asan Medical Center’s (AMC) Clinical Trial Center. The MOU formalises Novotech’s relationship with the internationally-leading medical center...
Research Insight
Vomaris Technology Impacts Biofilm-Induced Antibiotic Resistance
Vomaris Innovations, Inc. announced a notable presentation of clinically relevant data on how exposure to electric fields generated by their Advanced Microcurrent Technology® disrupts biofilm-induced antibiotic resistance, at the Symposium on Advanced Wound Care (SAWC) and Wound Healing Society...
Research Insight
BBraun and Philips joins to innovate in ultrasound guided regional anesthesia and vascular access
Strategic alliance combines B. Braun’s leadership in regional anesthesia and Philips’ leadership in image guided therapy solutions with the aim to make regional anesthesia and vascular access easier to perform, leading to enhanced patient care and hospital efficiency. Xperius*...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read